These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
219 related articles for article (PubMed ID: 13742660)
21. The pharmacological evaluation of monoamine oxidase inhibitors. LESSIN AW Biochem Pharmacol; 1959 Nov; 2():290-8. PubMed ID: 14416030 [No Abstract] [Full Text] [Related]
22. Significance of monoamine oxidase inhibition for the pharmacological and clinical effects of hydrazine derivatives. PLETSCHER A Ann N Y Acad Sci; 1959 Sep; 80():1039-45. PubMed ID: 14433482 [No Abstract] [Full Text] [Related]
23. A non-hydrazine monoamine oxidase inhibitor with antihypertensive properties. HORWITZ D; SJOERDSMA A Proc Soc Exp Biol Med; 1961 Jan; 106():118-20. PubMed ID: 13716049 [No Abstract] [Full Text] [Related]
25. [Study of the action of the isopropylhydrazide of p-chlorophenoxyacetic acid (P.C. 603), a new monoamine oxidase inhibitor, in depressive states]. BORENSTEIN P; DABBAH M; KRAMARZ P; HENON C Ann Med Psychol (Paris); 1961 Oct; 119(2)():554-65. PubMed ID: 13871268 [No Abstract] [Full Text] [Related]
26. Monoamine oxidase inhibitors in the treatment of angina pectoris. RUSSEK HI Angiology; 1960 Feb; 11():76-80. PubMed ID: 14440277 [No Abstract] [Full Text] [Related]
27. Anticonvulsant properties of monoamine oxidase inhibitors. PROCKOP DJ; SHORE PA; BRODIE BB Ann N Y Acad Sci; 1959 Sep; 80():643-51. PubMed ID: 14434994 [No Abstract] [Full Text] [Related]
31. Preliminary investigation of phenelzine in the management of angina pectoris. ENDE M Angiology; 1960 Feb; 11():81-3. PubMed ID: 13820229 [No Abstract] [Full Text] [Related]
32. Reversal of the reserpine-induced depletion of brain serotonin by a monoamine oxidase inhibitor. CANAL N; MAFFEI-FACCIOLI A J Neurochem; 1959 Dec; 5():99-100. PubMed ID: 13807360 [No Abstract] [Full Text] [Related]
33. Cardiovascular activity of beta-phenylethylhydrazine (phenelzine). BEN M; WARREN M; DRINNON V; SCOTT C Angiology; 1960 Feb; 11():62-6. PubMed ID: 13798680 [No Abstract] [Full Text] [Related]
34. The importance of the monoamine oxidase inhibitors in cardiovascular disease. GRIFFITH GC Am J Cardiol; 1960 Dec; 6():1103-5. PubMed ID: 13708592 [No Abstract] [Full Text] [Related]
35. Experiences in the treatment of angina pectoris with monoamine oxidase inhibitors. OBLATH RW; GRIFFITH GC J Am Geriatr Soc; 1961 Jun; 9():427-31. PubMed ID: 13730182 [No Abstract] [Full Text] [Related]
36. On the mechanism of action of monoamine oxidase inhibitors in angina pectoris. PLETSCHER A; GEY KF J Am Geriatr Soc; 1961 Jun; 9():410-8. PubMed ID: 13736338 [No Abstract] [Full Text] [Related]
37. The inhibition of amine oxidase and the central stimulating action of the stereoisomeric amphetamines and 1-phenylethylamines. GRANA E; LILLA L Br J Pharmacol Chemother; 1959 Dec; 14(4):501-4. PubMed ID: 13828860 [TBL] [Abstract][Full Text] [Related]
38. Biochemical and pharmacological effects of the monoamine oxidase inhibitors, iproniazid, 1-phenyl-2-hydrazinopropane (JB 516) and 1-phenyl-3-hydrazinobutane (JB 835). SPECTOR S; SHORE PA; BRODIE BB J Pharmacol Exp Ther; 1960 Jan; 128():15-21. PubMed ID: 13833205 [No Abstract] [Full Text] [Related]
39. The THERAPEUTIC action of monoamine oxidase inhibitors. Angiology; 1960 Feb; 11():55-7. PubMed ID: 13856617 [No Abstract] [Full Text] [Related]
40. [Clinical experience with a new drug of the antidepressive series: phenelzine]. TORRIGIANI G Clin Ter; 1959 Oct; 17():382-7. PubMed ID: 13838955 [No Abstract] [Full Text] [Related] [Previous] [Next] [New Search]